Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
CCCC on Nasdaq
There are no Buy or Sell transactions made by Kenneth Carl Anderson since 14 Feb 2025
Holdings reported by Kenneth Carl Anderson for C4 Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
146,532 |
$282,806 |
$1.93 |
02 Jan 2026 |
Direct |
|
|
| Common Stock |
61,265 |
$159,901 |
$2.61 |
02 Jan 2026 |
By Cynthia E. Anderson 2016 Grantor Retained Annuity Trust |
|
|
| Common Stock |
61,265 |
$159,901 |
$2.61 |
02 Jan 2026 |
By Kenneth C. Anderson 2016 Grantor Retained Annuity Trust |
|
|
| Common Stock |
47,316 |
$123,494 |
$2.61 |
02 Jan 2026 |
By Spouse |
|
|
| Common Stock |
16,939 |
$44,210 |
$2.61 |
02 Jan 2026 |
By Cynthia E. Anderson 2015 Irrevocable Trust |
|
|
| Common Stock |
16,939 |
$44,210 |
$2.61 |
02 Jan 2026 |
By Kenneth C. Anderson 2015 Irrevocable Trust |
|
|
| Stock Option (Right to Buy) |
35,500 |
|
|
18 Jun 2025 |
Direct |
Common Stock |
|
Transactions reported by Kenneth Carl Anderson for C4 Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.